`

GlycoNex Inc

Pharmaceutical Manufacturing

Specialities :
Antibody production
Glycobiology
New drug development
Biosimilar
Sec-hplc

+3

revenue-icon Revenue
< 1M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About GlycoNex Inc

What does Glyconex inc do?+

GlycoNex Inc. was founded in 2001, in alliance with The Biomembrane Institute (TBI) from Washington University and Dr. Sen-Itiroh Hakomori, a member of the National Academy of Sciences (USA). GlycoNex was the first pharmaceutical company in Taiwan to combine cancer-related glycan identification with human monoclonal antibody development. GlycoNex Inc. possesses a complete and detailed technological platform for anti-glycan antibody development, including multiple acquired licensed patents. Our pipeline consists of new drug development in parallel with biosimilars. Our new drugs were selected and developed through a detailed antigen/antibody characterization and cell line development. In 2009, we licensed GNX8 to Otsuka Pharmaceutical...

What are Glyconex inc's specialties? +

Antibody production,glycobiology,new drug development,biosimilar,sec-hplc,glycobind,preclinical research,and anti-glycan antibody

What is Glyconex inc's industry? +

Glyconex inc operates in the Pharmaceutical manufacturing industry.

What is Glyconex inc's revenue? +

Glyconex inc's revenue is < 1m

What is Glyconex inc's company size? +

Glyconex inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.